These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1159 related items for PubMed ID: 34914121

  • 1. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
    Kaufmann B, Saba K, Schmidli TS, Stutz S, Bissig L, Britschgi AJ, Schaeren E, Gu A, Langenegger N, Sulser T, Eberli D, Keller EX, Hermanns T, Poyet C.
    Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
    [Abstract] [Full Text] [Related]

  • 2. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
    Mannaerts CK, Gayet M, Verbeek JF, Engelbrecht MRW, Savci-Heijink CD, Jager GJ, Gielens MPM, van der Linden H, Beerlage HP, de Reijke TM, Wijkstra H, Roobol MJ.
    Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
    [Abstract] [Full Text] [Related]

  • 3. Detection of clinically significant prostate cancer by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in smaller prostates.
    Dahl DM, Kim MM, Wu S, Lin SX, Crotty RK, Cornejo KM, Harisinghani MG, Feldman AS, Wu CL.
    Urol Oncol; 2022 Oct; 40(10):451.e9-451.e14. PubMed ID: 36008257
    [Abstract] [Full Text] [Related]

  • 4. [Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5].
    Liu Y, Yuan CW, Wu JY, Shen Q, Xiao JX, Zhao Z, Wang XY, Li XS, He ZS, Zhou LQ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct 18; 55(5):812-817. PubMed ID: 37807733
    [Abstract] [Full Text] [Related]

  • 5. Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series.
    Stabile A, Barletta F, Motterle G, Pellegrino F, Sorce G, Mazzone E, Scuderi S, Cirulli GO, Cucchiara V, Esposito A, Gandaglia G, Fossati N, De Cobelli F, Montorsi F, Karnes RJ, Briganti A.
    Prostate Cancer Prostatic Dis; 2021 Dec 18; 24(4):1137-1142. PubMed ID: 33941867
    [Abstract] [Full Text] [Related]

  • 6. A clinical available decision support scheme for optimizing prostate biopsy based on mpMRI.
    Hou Y, Jiang KW, Zhang J, Bao ML, Shi HB, Qu JR, Cheng G, Zhang YD.
    Prostate Cancer Prostatic Dis; 2022 Apr 18; 25(4):727-734. PubMed ID: 35067674
    [Abstract] [Full Text] [Related]

  • 7. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions.
    Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L.
    J Urol; 2022 Feb 18; 207(2):333-340. PubMed ID: 34555925
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.
    Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P.
    Prostate; 2023 Feb 18; 83(2):162-168. PubMed ID: 36259316
    [Abstract] [Full Text] [Related]

  • 9. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
    Mannaerts CK, Engelbrecht MRW, Postema AW, van Kollenburg RAA, Hoeks CMA, Savci-Heijink CD, Van Sloun RJG, Wildeboer RR, De Reijke TM, Mischi M, Wijkstra H.
    BJU Int; 2020 Oct 18; 126(4):481-493. PubMed ID: 32315112
    [Abstract] [Full Text] [Related]

  • 10. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection.
    Wajswol E, Winoker JS, Anastos H, Falagario U, Okhawere K, Martini A, Treacy PJ, Voutsinas N, Knauer CJ, Sfakianos JP, Lewis SC, Taouli BA, Rastinehad AR.
    BJU Int; 2020 Apr 18; 125(4):531-540. PubMed ID: 31762182
    [Abstract] [Full Text] [Related]

  • 11. How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series.
    Barletta F, Stabile A, Mazzone E, Brembilla G, Sorce G, Pellegrino F, Scuderi S, Cannoletta D, Cirulli GO, Cucchiara V, Gandaglia G, De Cobelli F, Montorsi F, Briganti A.
    Urol Oncol; 2022 Mar 18; 40(3):103.e17-103.e24. PubMed ID: 34688534
    [Abstract] [Full Text] [Related]

  • 12. Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohort.
    Chaloupka M, Pyrgidis N, Ebner B, Volz Y, Pfitzinger PL, Berg E, Enzinger B, Atzler M, Ivanova T, Clevert DA, Buchner A, Stief CG, Apfelbeck M.
    BJU Int; 2024 May 18; 133(5):548-554. PubMed ID: 38060339
    [Abstract] [Full Text] [Related]

  • 13. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.
    Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, Raj G, Margulis V, Cadeddu JA, Lotan Y, Francis F, Pedrosa I, G Roehrborn C, Costa DN.
    Urol Oncol; 2019 Jan 18; 37(1):57-62. PubMed ID: 30446460
    [Abstract] [Full Text] [Related]

  • 14. Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer.
    Stabile A, Dell'Oglio P, Soligo M, De Cobelli F, Gandaglia G, Fossati N, Esposito A, Brembilla G, Karnes RJ, Montorsi F, Briganti A.
    Eur Urol Oncol; 2021 Aug 18; 4(4):594-600. PubMed ID: 31204312
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the optimal strategy in men with a single unilateral suspicious lesion on MRI undergoing transperineal MRI/ultrasound fusion prostate biopsy.
    Yusim I, Mazor E, Frumkin E, Jabareen M, Hefer B, Elsaraya N, Li S, Rouvinov K, Novack V, Mabjeesh NJ.
    Prostate; 2023 Sep 18; 83(13):1255-1262. PubMed ID: 37263774
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
    Choi YH, Kang MY, Sung HH, Jeon HG, Chang Jeong B, Seo SI, Jeon SS, Kim CK, Park BK, Lee HM.
    Clin Genitourin Cancer; 2019 Feb 18; 17(1):e19-e25. PubMed ID: 30415878
    [Abstract] [Full Text] [Related]

  • 17. The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy.
    Mannaerts CK, Kajtazovic A, Lodeizen OAP, Gayet M, Engelbrecht MRW, Jager GJ, Wijkstra H, de Reijke TM, Beerlage HP.
    Urol Oncol; 2019 May 18; 37(5):298.e1-298.e9. PubMed ID: 30660493
    [Abstract] [Full Text] [Related]

  • 18. Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series.
    Pellegrino F, Stabile A, Mazzone E, Sorce G, Barletta F, De Angelis M, Brembilla G, Gandaglia G, De Cobelli F, Montorsi F, Briganti A.
    Prostate; 2022 Sep 18; 82(12):1170-1175. PubMed ID: 35538401
    [Abstract] [Full Text] [Related]

  • 19. Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.
    Deniffel D, Perlis N, Ghai S, Girgis S, Healy GM, Fleshner N, Hamilton R, Kulkarni G, Toi A, van der Kwast T, Zlotta A, Finelli A, Haider MA.
    Eur Radiol; 2022 Nov 18; 32(11):7544-7554. PubMed ID: 35507051
    [Abstract] [Full Text] [Related]

  • 20. Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database.
    Barletta F, Mazzone E, Stabile A, Scuderi S, Brembilla G, de Angelis M, Cirulli GO, Cucchiara V, Gandaglia G, Karnes RJ, Roupret M, De Cobelli F, Montorsi F, Briganti A.
    World J Urol; 2022 Nov 18; 40(11):2683-2688. PubMed ID: 36149448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.